Shares of Lupin and Shilpa Medicare are down between 14% to 15% so far in 2025, while Natco Pharma has been the underperformer, with the stock having declined 40% so far this year.
Shares of Lupin and Shilpa Medicare are down between 14% to 15% so far in 2025, while Natco Pharma has been the underperformer, with the stock having declined 40% so far this year.